` VSC (4Sc AG) vs DAX Index Comparison - Alpha Spread

VSC
vs
DAX Index

Over the past 12 months, VSC has underperformed DAX Index, delivering a return of -80% compared to DAX Index's +13% growth.

Stocks Performance
VSC vs DAX Index

Loading...
VSC
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
VSC vs DAX Index

Loading...
VSC
DAX Index
Difference
www.alphaspread.com

Performance By Year
VSC vs DAX Index

Loading...
VSC
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
4Sc AG vs Peers

DAX Index
VSC
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

4Sc AG
Glance View

Market Cap
1.1m EUR
Industry
Biotechnology

4SC AG is a clinical-stage biopharmaceutical company, which engages in the development of small molecule drugs that target key indications in cancer. The company is headquartered in Planegg, Bayern and currently employs 14 full-time employees. The company went IPO on 2008-02-25. The Company’s product pipeline includes several anti-cancer drugs, which are in various stages of preclinical and clinical development. Its main products are Resminostat, an orally administered histone deacetylase (HDAC) inhibitor for the treatment of a broad spectrum of oncology indications, both in monotherapy in combination with other anti-cancer drugs; 4SC-202, an orally administered small molecule and epigenetic modulator that inhibits the enzymes lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) 1, 2, 3, and 4SC-208, a small molecule that targets two kinases for Hedgehog/GLI signaling.

VSC Intrinsic Value
Not Available
Back to Top